希腊慢性淋巴细胞白血病（CLL）治疗共识
Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment.
作者信息
Sachanas Sotirios, Vassilakopoulos Theodoros, Angelopoulou Maria, Papageorgiou Sotirios, Spanoudakis Emmanouil, Bouzani Maria, Dimou Maria, Panagiotidis Panagiotis
机构信息
Department of Hematology, Athens Medical Center, Psychikon Branch, Athens, Greece.
Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
出版信息
Mediterr J Hematol Infect Dis. 2025 Mar 1;17(1):e2025014. doi: 10.4084/MJHID.2025.014. eCollection 2025.
New targeted therapies have revolutionized the treatment landscape in CLL. Biological features, patient characteristics and preferences and the safety profile of each treatment option should be taken into consideration for making the optimal treatment choice. This consensus practice statement on CLL treatment was developed by a group of Greek experts in CLL based on the available evidence for both first-line treatment and the relapsed/refractory setting.
新的靶向治疗彻底改变了慢性淋巴细胞白血病（CLL）的治疗格局。在做出最佳治疗选择时，应考虑生物学特征、患者特点和偏好以及每种治疗方案的安全性。这份关于CLL治疗的共识性实践声明由一群希腊CLL专家根据一线治疗和复发/难治性情况的现有证据制定。
Zotero 插件